Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

In Category

Filter By

We narrowed to 192 results for: cell

Showing: 41 - 60 of 192 results

  1. pAAV-EF1a-fDIO-Cre (AAV9)

    Viral Prep
    #121675-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Esteban Engel, Alexander Nectow
    Article
    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30
    Promoter
    EF1a
    Tags
    None
    Available Since
    June 4, 2019
    Availability
    Academic Institutions and Nonprofits only

  2. pAAV-EF1a-Con/Fon-GCaMP6M (AAV8)

    Viral Prep
    #137119-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EF1a-Con/Fon-GCaMP6M (#137119). In addition to the viral particles, you will also receive purified pAAV-EF1a-Con/Fon-GCaMP6M plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of GCaMP6M. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Tags
    None
    Available Since
    Sept. 24, 2020
    Availability
    Academic Institutions and Nonprofits only

  3. pAAV-EF1a-Cre (AAV11)

    Viral Prep
    #55636-AAV11
    Purpose
    Ready-to-use AAV11 particles produced from pAAV-EF1a-Cre (#55636). In addition to the viral particles, you will also receive purified pAAV-EF1a-Cre plasmid DNA. EF1a-driven expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Article
    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:
    Promoter
    EF1a
    Tags
    None
    Available Since
    July 16, 2025
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV-nEF-ChRmine-mScarlet (AAV8)

    Viral Prep
    #137158-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-nEF-ChRmine-mScarlet (#137158). In addition to the viral particles, you will also receive purified pAAV-nEF-ChRmine-mScarlet plasmid DNA. nEF-driven expression of ChRmine-mScarlet. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    nEF
    Tags
    mScarlet
    Available Since
    April 8, 2021
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-Ef1a-Con/Fon-GCaMP6F (AAV8)

    Viral Prep
    #137122-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Con/Fon-GCaMP6F (#137122). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Fon-GCaMP6F plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of GCaMP6f. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Tags
    None
    Available Since
    March 12, 2021
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-Ef1a-Con/Fon-sRGECO (AAV8)

    Viral Prep
    #137126-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Con/Fon-sRGECO (#137126). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Fon-sRGECO plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of cytosolic sRGECO calcium sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Tags
    None
    Available Since
    April 5, 2021
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV_hSyn_WiChR_TS_mScarlet_ER (AAV9)

    Viral Prep
    #205997-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV_hSyn_WiChR_TS_mScarlet_ER (#205997). In addition to the viral particles, you will also receive purified pAAV_hSyn_WiChR_TS_mScarlet_ER plasmid DNA. hSyn-driven K+ selective channelrhodopsin for optogenetic inhibition of neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Peter Hegemann, Johannes Vierock
    Article
    Vierock et al Sci Adv. 2022 Nov 16:eadd7729.
    Promoter
    Syn
    Tags
    mScarlet
    Available Since
    July 30, 2025
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-EF1a-Flpo (AAV2)

    Viral Prep
    #55637-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Article
    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:
    Promoter
    EF1a
    Tags
    None
    Available Since
    March 18, 2024
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV-Ef1a-Coff/Fon-GCaMP6F (AAV8)

    Viral Prep
    #137124-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Coff/Fon-GCaMP6F (#137124). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Coff/Fon-GCaMP6F plasmid DNA. EF1a-driven, Flp-dependent expression of GCaMP6f (inhibited in presence of Cre). These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Tags
    None
    Available Since
    May 18, 2021
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-Ef1a-Con/Fon-GCaMP6F (AAV5)

    Viral Prep
    #137122-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Ef1a-Con/Fon-GCaMP6F (#137122). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Fon-GCaMP6F plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of GCaMP6f. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Tags
    None
    Available Since
    July 17, 2020
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-EF1a-C-CreintG (AAV1)

    Viral Prep
    #69571-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-C-CreintG (#69571). In addition to the viral particles, you will also receive purified pAAV-EF1a-C-CreintG plasmid DNA. EF1a-driven expression of optimized C-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-N-CretrcintG (Addgene catalog# 69570) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Connie Cepko
    Article
    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do
    Promoter
    EF1a
    Tags
    None
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-EF1a-N-CretrcintG (AAV1)

    Viral Prep
    #69570-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-N-CretrcintG (#69570). In addition to the viral particles, you will also receive purified pAAV-EF1a-N-CretrcintG plasmid DNA. EF1a-driven expression of optimized N-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-C-CreintG (Addgene catalog# 69571) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Connie Cepko
    Article
    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do
    Promoter
    EF1a
    Tags
    None
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only

  13. pTR-UF11 (AAV.A01.T)

    Viral Prep
    #157970-AAV.A01.T
    Purpose
    Ready-to-use AAV2 in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter
    Depositor
    Sergei Zolotukhin
    Article
    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10
    Promoter
    chimeric CMV/Chicken Beta actin (CBA)
    Tags
    GFP
    Available Since
    Dec. 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-hSyn1-Flex-mRuby2-GSG-P2A-GCaMP6s-WPRE-pA (AAV1)

    Viral Prep
    #68720-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn1-Flex-mRuby2-GSG-P2A-GCaMP6s-WPRE-pA (#68720). In addition to the viral particles, you will also receive purified pAAV-hSyn1-Flex-mRuby2-GSG-P2A-GCaMP6s-WPRE-pA plasmid DNA. Cre-dependent GCaMP6s calcium sensor and bicistronic, physically separate mRuby2 expression under a human synapsin1 promoter. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tobias Bonhoeffer, Tobias Rose, Mark Huebener
    Article
    Rose et al Science. 2016 Jun 10;352(6291):1319-22.
    Promoter
    hSyn1-FLEX
    Tags
    mRuby2 (Cre-dependent)
    Available Since
    March 7, 2018
    Availability
    Academic Institutions and Nonprofits only

  15. pTR-UF11 (AAV.A09.T)

    Viral Prep
    #157970-AAV.A09.T
    Purpose
    Ready-to-use AAV6 in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter
    Depositor
    Sergei Zolotukhin
    Article
    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10
    Promoter
    chimeric CMV/Chicken Beta actin (CBA)
    Tags
    GFP
    Available Since
    Dec. 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-nEF-NpHR3.3-EYFP (AAV8)

    Viral Prep
    #137151-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-nEF-NpHR3.3-EYFP (#137151). In addition to the viral particles, you will also receive purified pAAV-nEF-NpHR3.3-EYFP plasmid DNA. nEF-driven expression of NpHR3.3-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    nEF
    Tags
    EYFP
    Available Since
    May 5, 2021
    Availability
    Academic Institutions and Nonprofits only

  17. pTR-UF11 (AAV.A11.T)

    Viral Prep
    #157970-AAV.A11.T
    Purpose
    Ready-to-use AAV44.9 in PBS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter
    Depositor
    Sergei Zolotukhin
    Article
    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10
    Promoter
    chimeric CMV/Chicken Beta actin (CBA)
    Tags
    GFP
    Available Since
    Dec. 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-EF1a-vCre (AAV8)

    Viral Prep
    #55638-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EF1a-vCre (#55638). In addition to the viral particles, you will also receive purified pAAV-EF1a-vCre plasmid DNA. EF1a-driven expression of VCre. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Article
    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:
    Promoter
    EF1a
    Tags
    None
    Available Since
    Nov. 12, 2020
    Availability
    Academic Institutions and Nonprofits only

  19. pTR-UF11 (AAV.A07.T)

    Viral Prep
    #157970-AAV.A07.T
    Purpose
    Ready-to-use AAV2 (trpYF) in BSS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter
    Depositor
    Sergei Zolotukhin
    Article
    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10
    Promoter
    chimeric CMV/Chicken Beta actin (CBA)
    Tags
    GFP
    Available Since
    Dec. 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  20. pTR-UF11 (AAV.A06.T)

    Viral Prep
    #157970-AAV.A06.T
    Purpose
    Ready-to-use AAV2 (trpYF) in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter
    Depositor
    Sergei Zolotukhin
    Article
    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10
    Promoter
    chimeric CMV/Chicken Beta actin (CBA)
    Tags
    GFP
    Available Since
    Dec. 21, 2020
    Availability
    Academic Institutions and Nonprofits only
Showing: 41 - 60 of 192 results